Related Experiment Videos
Neopterin and human immunodeficiency virus infection
1Hvidovre Hospital, Municipality of Copenhagen University, Department of Infectious Diseases, Denmark.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies
|April 1, 1993
Summary
Neopterin levels rise early in HIV infection, signaling immune system activation. These elevated neopterin concentrations can predict disease progression and aid in evaluating new HIV treatments.
Area of Science:
- Immunology
- Virology
- Biochemistry
Background:
- Human Immunodeficiency Virus (HIV) infection triggers a complex immune response.
- Monitoring immune activation is crucial for understanding HIV pathogenesis and treatment efficacy.
Purpose of the Study:
- To investigate the role of neopterin as a biomarker in HIV infection.
- To assess the correlation between neopterin levels, immune cell counts, and clinical disease progression.
Main Methods:
- Serum and urine neopterin concentrations were measured in individuals with HIV.
- Neopterin levels were compared with CD4 T cell counts and clinical outcomes.
Main Results:
- Neopterin concentrations increased within the first week of HIV infection and remained elevated.
- Changes in neopterin preceded declines in CD4 T cells and clinical disease development.
- Elevated neopterin levels predicted the later development of Acquired Immunodeficiency Syndrome (AIDS).
Conclusions:
- Increased neopterin indicates immune system activation and virus-immune system interaction in HIV infection.
- Neopterin measurements show potential for predicting HIV disease progression.
- Neopterin assays may facilitate rapid evaluation of novel HIV therapeutics.